Literature DB >> 19281850

3 T MRI relaxometry detects T2 prolongation in the cerebral normal-appearing white matter in multiple sclerosis.

Mohit Neema1, Daniel Goldberg-Zimring, Zachary D Guss, Brian C Healy, Charles R G Guttmann, Maria K Houtchens, Howard L Weiner, Mark A Horsfield, David B Hackney, David C Alsop, Rohit Bakshi.   

Abstract

MRI at 3 T has increased sensitivity in detecting overt multiple sclerosis (MS) brain lesions; a growing body of data suggests clinically relevant damage occurs in the normal-appearing white matter (NAWM). We tested a novel pulse sequence to determine whether 3 T MRI spin-spin relaxometry detected damage in NAWM of MS patients (n=13) vs. age-matched normal controls [(NL) (n=11)]. Baseline characteristics of the MS group were: age (mean+/-SD) 42.5+/-5.4 (range 33-51 years), disease duration 9.0+/-6.4 (range 1-22 years), Expanded Disability Status Scale score 2.5+/-1.7 (range 1-6.5). Brain MRI measures, obtained at 3 T, included global and regional NAWM transverse relaxation rate [R2 (=1/T2)], derived from 3D fast spin-echo T2 prepared images, and global white matter volume fraction derived from SPGR images. The regional NAWM areas investigated were the frontal lobe, parietal lobe, and the genu and splenium of the corpus callosum. Mean NAWM R2 was lower (indicating T2 prolongation) in MS than NL in the whole brain (p=0.00047), frontal NAWM (p=0.00015), parietal NAWM (p=0.0069) and callosal genu (p=0.0019). Similarly, R2 histogram peak position was lower in NAWM in MS than NL in the whole brain (p=0.019). However, the normalized WM volume fractions were similar in both MS and NL (p>0.1). This pilot study suggests that a novel 3D fast spin-echo pulse sequence at 3 T, used to derive R2 relaxation maps, can detect tissue damage in the global and regional cerebral NAWM of MS patients that is missed by conventional lesion and atrophy measures. Such findings may represent demyelination, inflammation, glial proliferation and axonal loss.

Entities:  

Mesh:

Year:  2009        PMID: 19281850      PMCID: PMC2974316          DOI: 10.1016/j.neuroimage.2009.03.001

Source DB:  PubMed          Journal:  Neuroimage        ISSN: 1053-8119            Impact factor:   6.556


  51 in total

1.  Are mono-exponential fits to a few echoes sufficient to determine T2 relaxation for in vivo human brain?

Authors:  K P Whittall; A L MacKay; D K Li
Journal:  Magn Reson Med       Date:  1999-06       Impact factor: 4.668

2.  In vivo determination of multiexponential T2 relaxation in the brain of patients with multiple sclerosis.

Authors:  J P Armspach; D Gounot; L Rumbach; J Chambron
Journal:  Magn Reson Imaging       Date:  1991       Impact factor: 2.546

3.  T1 and T2 measurements on a 1.5-T commercial MR imager.

Authors:  R K Breger; A A Rimm; M E Fischer; R A Papke; V M Haughton
Journal:  Radiology       Date:  1989-04       Impact factor: 11.105

4.  Errors in T2 estimation using multislice multiple-echo imaging.

Authors:  A P Crawley; R M Henkelman
Journal:  Magn Reson Med       Date:  1987-01       Impact factor: 4.668

5.  Magnetic resonance relaxation time mapping in multiple sclerosis: normal appearing white matter and the "invisible" lesion load.

Authors:  S Barbosa; L D Blumhardt; N Roberts; T Lock; R H Edwards
Journal:  Magn Reson Imaging       Date:  1994       Impact factor: 2.546

6.  Evidence of elevated glutamate in multiple sclerosis using magnetic resonance spectroscopy at 3 T.

Authors:  Radhika Srinivasan; Napapon Sailasuta; Ralph Hurd; Sarah Nelson; Daniel Pelletier
Journal:  Brain       Date:  2005-03-09       Impact factor: 13.501

Review 7.  MRI in multiple sclerosis: current status and future prospects.

Authors:  Rohit Bakshi; Alan J Thompson; Maria A Rocca; Daniel Pelletier; Vincent Dousset; Frederik Barkhof; Matilde Inglese; Charles R G Guttmann; Mark A Horsfield; Massimo Filippi
Journal:  Lancet Neurol       Date:  2008-07       Impact factor: 44.182

8.  Measurement of T1 and T2 in the cervical spinal cord at 3 tesla.

Authors:  Seth A Smith; Richard A E Edden; Jonathan A D Farrell; Peter B Barker; Peter C M Van Zijl
Journal:  Magn Reson Med       Date:  2008-07       Impact factor: 4.668

9.  Precise relaxation time measurements of normal-appearing white matter in inflammatory central nervous system disease.

Authors:  D H Miller; G Johnson; P S Tofts; D MacManus; W I McDonald
Journal:  Magn Reson Med       Date:  1989-09       Impact factor: 4.668

10.  Long T2 water in multiple sclerosis: what else can we learn from multi-echo T2 relaxation?

Authors:  Cornelia Laule; Irene M Vavasour; Shannon H Kolind; Anthony L Traboulsee; G R Wayne Moore; David K B Li; Alex L Mackay
Journal:  J Neurol       Date:  2007-09-04       Impact factor: 6.682

View more
  27 in total

Review 1.  The radiologically isolated syndrome: take action when the unexpected is uncovered?

Authors:  Johann Sellner; Lucas Schirmer; Bernhard Hemmer; Mark Mühlau
Journal:  J Neurol       Date:  2010-05-26       Impact factor: 4.849

2.  In vivo quantitative evaluation of brain tissue damage in multiple sclerosis using gradient echo plural contrast imaging technique.

Authors:  Pascal Sati; Anne H Cross; Jie Luo; Charles F Hildebolt; Dmitriy A Yablonskiy
Journal:  Neuroimage       Date:  2010-03-23       Impact factor: 6.556

3.  T2 relaxometry measurements in low spatial frequency brain regions differ between fast spin-echo and multiple-echo spin-echo sequences.

Authors:  Venkateswaran Rajagopalan; Mark J Lowe; Erik B Beall; Guang H Yue; Erik P Pioro
Journal:  MAGMA       Date:  2013-01-26       Impact factor: 2.310

4.  Human brain iron mapping using atlas-based T2 relaxometry.

Authors:  Khader M Hasan; Indika S Walimuni; Larry A Kramer; Ponnada A Narayana
Journal:  Magn Reson Med       Date:  2011-06-23       Impact factor: 4.668

5.  Multi-modal quantitative MRI investigation of brain tissue neurodegeneration in multiple sclerosis.

Authors:  Khader M Hasan; Indika S Walimuni; Humaira Abid; Jerry S Wolinsky; Ponnada A Narayana
Journal:  J Magn Reson Imaging       Date:  2012-01-12       Impact factor: 4.813

Review 6.  [Radiologically isolated syndrome: multiple sclerosis based solely on MRI findings?].

Authors:  J Sellner; L Schirmer; B Hemmer; M Mühlau
Journal:  Nervenarzt       Date:  2010-10       Impact factor: 1.214

7.  Myelin-targeted, texaphyrin-based multimodal imaging agent for magnetic resonance and optical imaging.

Authors:  Sashiprabha M Vithanarachchi; Casey D Foley; Sarah Trimpin; James R Ewing; Meser M Ali; Matthew J Allen
Journal:  Contrast Media Mol Imaging       Date:  2016-09-06       Impact factor: 3.161

8.  Potential clinical impact of multiparametric quantitative MR spectroscopy in neurological disorders: A review and analysis.

Authors:  Ivan I Kirov; Assaf Tal
Journal:  Magn Reson Med       Date:  2019-08-08       Impact factor: 4.668

9.  Reduced field-of-view diffusion-weighted imaging of the brain at 7 T.

Authors:  Cornelius von Morze; Douglas A C Kelley; Timothy M Shepherd; Suchandrima Banerjee; Duan Xu; Christopher P Hess
Journal:  Magn Reson Imaging       Date:  2010-09-17       Impact factor: 2.546

10.  Brain MRI lesion load at 1.5T and 3T versus clinical status in multiple sclerosis.

Authors:  James M Stankiewicz; Bonnie I Glanz; Brian C Healy; Ashish Arora; Mohit Neema; Ralph H B Benedict; Zachary D Guss; Shahamat Tauhid; Guy J Buckle; Maria K Houtchens; Samia J Khoury; Howard L Weiner; Charles R G Guttmann; Rohit Bakshi
Journal:  J Neuroimaging       Date:  2011-04       Impact factor: 2.486

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.